The preparation and nature of the first International Standard for Glucagon are described. The glucagon activity of this material was compared with that of the U. S. P. Glucagon Reference Standard in a collaborative assay by 3 
Design of the study Participants were asked to assay the proposed international standard for glucagon against the U. S. P. Glucagon Reference Standard by any method of biological assay in which they had experience and confidence.
It was requested that each participant should carry out a minimum of three in¬ dependent assays, and that each assay should be performed using a freshly opened ampoule and a new set of dilutions.
Assays contributed to the study The three participating laboratories carried out a total of 30 assays. Each assay was allocated a number, the first part identifying the laboratory and the second part referring to the number of the assay within that laboratory. Names of participants are listed in the Annex in an order which is different from the code numbers assigned to laboratories.
In each assay the proposed international standard for glucagon was compared with the U. S. P. Glucagon Reference Standard. Participants carried out assays in which the increase of blood glucose levels induced by glucagon, was measured in rabbits (twin cross-over design), mice (twin cross-over) or cats (U. S. P. design with five 4x4 Latin squares). Details of the assay methods and designs are given in Table 1 .
RESULTS

Assays by the rabbit twin cross-over method
The three laboratories carried out a total of 13 twin cross-over assays in rabbits, based essentially on the method reported by Tar ding et al. (1969) . The hyperglycaemic response was expressed either as the sum of the final blood glucose levels or as the difference between initial and final levels, according to the practice of the laboratory (see Table 1 ). Using this as response metameter, assays were analysed by the parallel-line method relating response to log-dose (as described, for example, by Finney (1964) ). Each of the 14 assays, with the exception of assay 1.18 (significant nonparallelism, 0.01 < < 0.05), was considered statistically valid for potency estimation (see Table 2 ).
The 13 valid potency estimates are slightly heterogeneous but not seriously so ( 2 2 = 21.71, 0.01 < P <C 0.05), and were combined in the same manner as the rabbit twin cross-over assays to give a value of 1.49 U. S. P. glucagon units/ampoule with 95% fiducial limits of 1.41-1.58.
3. Assays on cats, based on the U. S. P. method Laboratory 2 carried out three assays on cats based on the method detailed in the United States Pharmacopoeia XVIII (1970) . Each assay involved 20 cats and the two doses of each preparation were arranged in 4 4 Latin squares, according to cat and time of dose. Thus an assay consisted of five such Latin squares, three of which were replicates of one arrangement and two of a second arrangement. The hyperglycaemic response was measured as the dif¬ ference between the initial blood glucose level and the higher of the two readings that followed injection of the glucagon preparations (see Table 1 ). Each of the three assays was considered statistically valid for potency esti¬ mation (see Table 2 ). 
